← Dashboard
Pipeline: Profile → Scout → Research → Draft → Applied

a16z Bio + Health

HIGH Tx Startup
Strategy Notes
a16z Bio is a tier-1 biotech VC with deep expertise in AI/ML-driven drug discovery and protein engineering—strong sector/thesis match. However, the provided page is primarily podcast content, not a structured funding program; a16z Bio's typical pre-seed checks may exceed the €30K floor and fall short of the €2.5M ceiling. Worth pursuing as direct VC inquiry but verify current ticket size and thesis focus.
Key Materials
—
Your Notes
Status & Deadline
Status
HUMAN_REQUIRED
Deadline
rolling
Cycle
rolling
Amount
—
Type
vc
URL
Apply
Update Status
Log Application
AI Pipeline
Research Programme Generate Draft
Status History
2026-07-09 HUMAN_REQUIRED → HUMAN_REQUIRED · a16z Bio + Health has no public application form or structured portal; the standard path is a warm introduction to a Bio team partner (Julie Yoo, Jorge Conde, Vijay Pande, or Hanne Winarsky) or a carefully targeted cold email with a one-pager attached. If interest is established, partners request a pitch meeting and then conduct technical and commercial due diligence before a term sheet. Eniola should leverage existing network nodes—SEMIA, Quest for Health contacts, Paris-Saclay affiliates—for an introduction, and verify current check-size appetite before investing significant time, as a16z Bio's typical seed ticket ($2M–$10M) may exceed the €2.5M non-dilutive ceiling and their investments are predominantly US-incorporated entities.
2026-07-09 HUMAN_REQUIRED → HUMAN_REQUIRED · a16z Bio + Health has no public application form or structured portal; the standard path is a warm introduction to a Bio team partner (Julie Yoo, Jorge Conde, Vijay Pande, or Hanne Winarsky) or a carefully targeted cold email with a one-pager attached. If interest is established, partners request a pitch meeting and then conduct technical and commercial due diligence before a term sheet. Eniola should leverage existing network nodes—SEMIA, Quest for Health contacts, Paris-Saclay affiliates—for an introduction, and verify current check-size appetite before investing significant time, as a16z Bio's typical seed ticket ($2M–$10M) may exceed the €2.5M non-dilutive ceiling and their investments are predominantly US-incorporated entities.
2026-07-09 OPEN → HUMAN_REQUIRED · a16z Bio + Health has no public application form or structured portal; the standard path is a warm introduction to a Bio team partner (Julie Yoo, Jorge Conde, Vijay Pande, or Hanne Winarsky) or a carefully targeted cold email with a one-pager attached. If interest is established, partners request a pitch meeting and then conduct technical and commercial due diligence before a term sheet. Eniola should leverage existing network nodes—SEMIA, Quest for Health contacts, Paris-Saclay affiliates—for an introduction, and verify current check-size appetite before investing significant time, as a16z Bio's typical seed ticket ($2M–$10M) may exceed the €2.5M non-dilutive ceiling and their investments are predominantly US-incorporated entities.
2026-07-09 HUMAN_REQUIRED → HUMAN_REQUIRED · a16z Bio + Health has no public application form or structured portal; the standard path is a warm introduction to a Bio team partner (Julie Yoo, Jorge Conde, Vijay Pande, or Hanne Winarsky) or a carefully targeted cold email with a one-pager attached. If interest is established, partners request a pitch meeting and then conduct technical and commercial due diligence before a term sheet. Eniola should leverage existing network nodes—SEMIA, Quest for Health contacts, Paris-Saclay affiliates—for an introduction, and verify current check-size appetite before investing significant time, as a16z Bio's typical seed ticket ($2M–$10M) may exceed the €2.5M non-dilutive ceiling and their investments are predominantly US-incorporated entities.